If you’ve been diagnosed with T1a renal cell carcinoma (RCC), a form of kidney cancer, VIE offers a minimally invasive solution: cryoablation. Our team of experts brings decades of experience and advanced technologies to provide this effective alternative to surgery, prioritizing your comfort and safety throughout the process.
What is cryoablation?
Cryoablation is a minimally invasive procedure that uses extreme cold to destroy cancer cells. It’s particularly effective for treating T1a renal cell carcinomas, which are tumors 4 cm or less in size and is an excellent option for patients who may not be suitable for surgery.
Our team of experts has extensive experience performing cryoablation procedures. We prioritize patient comfort and safety, ensuring the procedure is as painless and efficient as possible. Our success rates are a testament to our expertise and dedication.
How we perform cryoablation
Our team continues to provide comprehensive care after the procedure. We monitor your recovery and guide post-procedure care. Our team is always available to answer any questions and address any concerns.
Frequently Asked Questions about Cryoablation for Renal Cell Carcinoma (RCC)
Most patients can go home the same day after the procedure. There may be some discomfort in the treated area, which can usually be managed with over-the-counter pain medication. Most people can return to their normal activities within a week.
The procedure itself typically takes about 1-2 hours. However, preparation and recovery time means you should expect to be at the clinic for a few hours.
